Novartis Pharma AG researches, develops, manufactures and commercializes prescription medicines and therapies. It focuses on therapeutic areas including oncology, neuroscience, immunology and cardiovascular, renal and metabolic diseases, and employs technology platforms such as small‑molecule chemistry, biotherapeutics, RNA‑based approaches, radioligand therapy and gene and cell therapies.